Completed
Dabrafenib, Trametinib and Hydroxychloroquine in Patients With Advanced BRAF Mutant Melanoma
NCT02257424
- Conditions
- Advanced BRAF Mutant Melanoma
- Locations
-
- Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States